Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Nonparametric Statistics01:28

Introduction to Nonparametric Statistics

1.4K
Nonparametric statistics offer a powerful alternative to traditional parametric methods, useful when assumptions about the population distribution cannot be made. Unlike parametric tests, which require data to follow a specific distribution with well-defined parameters (such as the mean and standard deviation), nonparametric tests do not require such constraints. This makes them particularly valuable when dealing with small sample sizes, skewed data, or ordinal and categorical variables.
One of...
1.4K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Group Design02:01

Group Design

10.7K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.7K
Factorial Design02:01

Factorial Design

14.1K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.

Journal for immunotherapy of cancer·2026
Same author

RxMap: an LLM-assisted tool for medication normalization.

JAMIA open·2026
Same author

A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.

Liver cancer·2026
Same author

Time-resolved EEG decoding reveals altered neural dynamics of affective semantic evaluation in depression and suicidality.

Communications biology·2026
Same author

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.

The oncologist·2026
Same author

Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series.

NPJ precision oncology·2025

Related Experiment Video

Updated: Feb 10, 2026

Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
09:36

Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study

Published on: June 6, 2025

605

A nonparametric Bayesian basket trial design.

Yanxun Xu1, Peter Müller2, Apostolia M Tsimberidou3

  • 1Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, 21218, USA.

Biometrical Journal. Biometrische Zeitschrift
|May 30, 2018
PubMed
Summary
This summary is machine-generated.

Identifying patient subpopulations for targeted cancer therapies is crucial. This study introduces an adaptive Bayesian clinical trial design for precise patient allocation and subpopulation identification, improving treatment efficacy.

Keywords:
Bayesian adaptive designsbasket trialssubpopulation identificationtargeted therapies

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
An Assessment Method and Toolkit to Evaluate Keyboard Design on Smartphones
05:42

An Assessment Method and Toolkit to Evaluate Keyboard Design on Smartphones

Published on: October 5, 2020

3.7K

Related Experiment Videos

Last Updated: Feb 10, 2026

Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study
09:36

Standardization of Basket Use in Sialendoscopy: A Ten-Year Retrospective Study

Published on: June 6, 2025

605
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
An Assessment Method and Toolkit to Evaluate Keyboard Design on Smartphones
05:42

An Assessment Method and Toolkit to Evaluate Keyboard Design on Smartphones

Published on: October 5, 2020

3.7K

Area of Science:

  • Oncology
  • Biostatistics
  • Genomics

Background:

  • Genomic aberration analysis guides targeted cancer therapies, improving prognosis and treatment outcomes.
  • Matching patients to therapies based on specific genomic alterations is a key strategy in cancer management.
  • Identifying patient subpopulations who benefit most from targeted therapies across diverse cancer types is essential.

Purpose of the Study:

  • To propose an adaptive Bayesian clinical trial design for effective patient allocation and subpopulation identification.
  • To develop a decision-theoretic framework incorporating utility functions and probability models for subpopulation analysis.
  • To enable adaptive allocation of patients to superior treatments based on identified subpopulations.

Main Methods:

  • Utilizing a flexible nonparametric Bayesian survival regression with random covariate-dependent patient partitioning.
  • Employing a decision-theoretic approach with a flexible utility function reflecting clinical requirements.
  • Implementing adaptive patient allocation to optimize treatment assignment within identified subpopulations.

Main Results:

  • The proposed adaptive Bayesian design demonstrates desirable operating characteristics through extensive simulations.
  • The method effectively identifies patient subpopulations likely to benefit from specific targeted therapies.
  • Simulation studies show favorable comparisons against alternative clinical trial designs.

Conclusions:

  • The developed adaptive Bayesian clinical trial design offers a robust method for patient allocation and subpopulation identification in targeted cancer therapy.
  • This approach facilitates personalized medicine by matching patients to the most effective aberration-specific treatments.
  • The findings support the advancement of precision oncology through optimized clinical trial strategies.